Zeaxanthin
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06270680 | Aug → Nov 2024 | brain injury, carotenemia | Penn State University | Completed | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT05232409 | Apr 2022 → Mar 2028 expected | metastatic malignant neoplasm | Valley Health System | Recruiting | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT03750968 | Sep 2019 → Jan 2022 | nutritional deficiency disease, pregnancy disorder | Paul S. Bernstein | Completed | No outcome recorded |
| Phase 2 | NCT02062034 | Feb 2011 → Nov 2013 | diabetic retinopathy, type 2 diabetes mellitus | University of Guadalajara | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03702374 | Sep 2018 → Nov 2020 | diabetic retinopathy | University of Guadalajara | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03340103 | Oct 2018 → Oct 2019 | — | Sooft Italia | Withdrawn | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT03959592 Comparator | Aug 2019 → Nov 2021 | glaucoma | Felipe Medeiros, MD | Terminated | No outcome recorded |
| Phase 1/2 | NCT01048476 Comparator | Sep 2009 → Apr 2012 | age-related macular degeneration | Peking University | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT04071977 Comparator | Mar 2020 → Oct 2021 | diabetes mellitus, diabetic retinopathy | University of Guadalajara | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00345176 Comparator | Sep 2006 → Oct 2012 | age-related macular degeneration, cataract | National Eye Institute (NEI) | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00914576 Comparator | Apr 2011 → Jul 2013 | — | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 14 cited values
Every value below carries the sentence it was read from. 13 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | zeaxanthin | “It consists in a tablet with lutein (10 mg), astaxanthin (4 mg), Zeaxanthin (1mg), vitamin C (L-ascorbic acid 180mg), vitamin E (DL-alpha tocopherol 30mg), zinc (zinc oxide...” NCT03702374 ↗10“(1 mg copper, 20 mg zinc, 180 mg vitamin C, 30 mg vitamin E, 1 mg zeaxanthin, 4 mg astaxanthin, 10 mg lutein) daily of oral, all of them in one Tablet for 24 weeks” NCT02062034 ↗ “LUTEIN ofta 0,5 gocce, containing a solution of 5% Lutein and 2,5% Zeaxanthin with excipients (Corn starch, glucose, potassium sorbate, xanthan gum, citric acid)” NCT03340103 ↗ “Each dose will consist of one supplement capsule containing 10 mg lutein, 2 mg zeaxanthin, 10 mg mesozeaxanthin, 50mg EPA, 250mg DHA.” NCT06270680 ↗ “containing: Zeaxanthin 5mg, Vitamin E 60mg, Copper 1mg, Selene 20µg, Ginko Biloba 10mg, Flavonoids 25mg, Alpha Lipon acid: 150mg” NCT00914576 ↗ “Softgel active ingredients: Lutein 10 mg and Zeaxanthin 2 mg in safflower oil” NCT03750968 ↗ “Zeaxanthin (1 mg)” NCT04071977 ↗ |
| Known as | Anchovyxanthin | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359248 ↗ |
| Known as | Aztec marigold zeaxanthin extract | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359248 ↗ |
| Known as | E 161H | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359248 ↗ |
| Known as | E-161H(I) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359248 ↗ |
| Known as | INS NO.161H(I) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359248 ↗ |
| Known as | INS-161H(I) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359248 ↗ |
| Known as | Luteinofta | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359248 ↗ |
| Known as | Optisharp | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359248 ↗ |
| Known as | Xanthophyll 3 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359248 ↗ |
| Known as | Zeagold | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359248 ↗ |
| Known as | Zeaxanthol | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359248 ↗ |
| Modality | Small molecule | — CHEMBL2359248 ↗ |
| Route | Oral | “daily oral supplementation with lutein/zeaxanthin” PMID 23645227 ↗ Jul 2013 |